A recent study also revealed that IGFBP4 mRNA expression is an independent prognostic factor in breast cancer, and that patients with ER-positive breast cancer with higher levels of IGFBP4 tumor mRNA expression and lower levels of IGFBP5 mRNA had a better prognosis [67]. This evidence concerns the gene IGFBP5 and neoplasm.